Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer
KING OF PRUSSIA, Pa., Sept. 17, 2013 /PRNewswire/ — Trevena, Inc., (Trevena) a clinical stage pharmaceutical company and a leader in the discovery and development of
«We are delighted to have Roberto join Trevena at this pivotal juncture in the company’s development," said Maxine Gowen, Ph. D., president and chief executive officer of Trevena. «Roberto’s diverse experience in effectively transitioning both private and public healthcare companies through phases of rapid growth will be invaluable in assisting Trevena through its corporate and strategic evolution.»
Mr. Cuca brings to Trevena nearly 20 years of experience in the pharmaceutical and biotechnology industries. Most recently, he served as Treasurer and Senior Vice President, Finance at Endo Health Solutions Inc., a specialty healthcare company. Before that, he was Director, Corporate and Business Development, at moksha8 Pharmaceuticals, Inc., a pharmaceutical company focused on emerging markets. Mr. Cuca also worked at JPMorgan Chase & Co. as an equity analyst covering U.S. pharmaceutical companies. He received an M.B.A. from the Wharton School of The University of Pennsylvania, a J.D. from Cornell Law School, an A.B. from Princeton University and he is a CFA charterholder.
«I am excited to join Trevena and work with its exceptional team at a time of such great promise," said Mr. Cuca. «The company has made significant progress in advancing its compounds into the clinic, collaborating with